img

Global Epigenetics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Epigenetics Market Insights, Forecast to 2034

Based on product, the global market for epigenetics, is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2017, the kits segment accounted for the largest share of global market for epigenetics. The large share of this segment is attributed to the fact that a large number of kits are used in epigenetic techniques. The rising prevalence of a number of diseases, increasing R&D spending, and increased government funding for life science research are the Others factors supporting market growth.
Market Analysis and InsightsGlobal Epigenetics Market
Global Epigenetics market is expected to reach to US$ 10740 million in 2024, with a positive growth of %, compared with US$ 9007.4 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Epigenetics industry is evaluated to reach US$ 27650 million in 2029. The CAGR will be 17.1% during 2024 to 2029.
Market growth can be attributed to the decreasing sequencing costs, increase in research activities, availability of funding for epigenetics research, and rising prevalence of cancer.
Report Covers
This report presents an overview of global Epigenetics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Epigenetics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific
Merck & Co.
Zymo Research
Abcam
Qiagen
Illumina
Active Motif
Bio-Rad
New England Biolabs
Agilent
Perkinelmer
Diagenode
Epizyme Inc.
CellCentric Ltd.
ValiRx plc
EpiGentek
Segment by Type
Enzymes
Kits & Assays
Instruments and Consumables
Reagents

Segment by Application


Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Epigenetics introduction, etc. Epigenetics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Epigenetics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Enzymes
1.2.3 Kits & Assays
1.2.4 Instruments and Consumables
1.2.5 Reagents
1.3 Market by Application
1.3.1 Global Epigenetics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Contract Research Organizations (CROs)
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenetics Market Perspective (2018-2029)
2.2 Global Epigenetics Growth Trends by Region
2.2.1 Epigenetics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Epigenetics Historic Market Size by Region (2018-2024)
2.2.3 Epigenetics Forecasted Market Size by Region (2024-2029)
2.3 Epigenetics Market Dynamics
2.3.1 Epigenetics Industry Trends
2.3.2 Epigenetics Market Drivers
2.3.3 Epigenetics Market Challenges
2.3.4 Epigenetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Epigenetics by Players
3.1.1 Global Epigenetics Revenue by Players (2018-2024)
3.1.2 Global Epigenetics Revenue Market Share by Players (2018-2024)
3.2 Global Epigenetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Epigenetics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Epigenetics Market Concentration Ratio
3.4.1 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Revenue in 2022
3.5 Global Key Players of Epigenetics Head office and Area Served
3.6 Global Key Players of Epigenetics, Product and Application
3.7 Global Key Players of Epigenetics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenetics Breakdown Data by Type
4.1 Global Epigenetics Historic Market Size by Type (2018-2024)
4.2 Global Epigenetics Forecasted Market Size by Type (2024-2029)
5 Epigenetics Breakdown Data by Application
5.1 Global Epigenetics Historic Market Size by Application (2018-2024)
5.2 Global Epigenetics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Epigenetics Market Size (2018-2029)
6.2 North America Epigenetics Market Size by Type
6.2.1 North America Epigenetics Market Size by Type (2018-2024)
6.2.2 North America Epigenetics Market Size by Type (2024-2029)
6.2.3 North America Epigenetics Market Share by Type (2018-2029)
6.3 North America Epigenetics Market Size by Application
6.3.1 North America Epigenetics Market Size by Application (2018-2024)
6.3.2 North America Epigenetics Market Size by Application (2024-2029)
6.3.3 North America Epigenetics Market Share by Application (2018-2029)
6.4 North America Epigenetics Market Size by Country
6.4.1 North America Epigenetics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Epigenetics Market Size by Country (2018-2024)
6.4.3 North America Epigenetics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Epigenetics Market Size (2018-2029)
7.2 Europe Epigenetics Market Size by Type
7.2.1 Europe Epigenetics Market Size by Type (2018-2024)
7.2.2 Europe Epigenetics Market Size by Type (2024-2029)
7.2.3 Europe Epigenetics Market Share by Type (2018-2029)
7.3 Europe Epigenetics Market Size by Application
7.3.1 Europe Epigenetics Market Size by Application (2018-2024)
7.3.2 Europe Epigenetics Market Size by Application (2024-2029)
7.3.3 Europe Epigenetics Market Share by Application (2018-2029)
7.4 Europe Epigenetics Market Size by Country
7.4.1 Europe Epigenetics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Epigenetics Market Size by Country (2018-2024)
7.4.3 Europe Epigenetics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Epigenetics Market Size (2018-2029)
8.2 China Epigenetics Market Size by Type
8.2.1 China Epigenetics Market Size by Type (2018-2024)
8.2.2 China Epigenetics Market Size by Type (2024-2029)
8.2.3 China Epigenetics Market Share by Type (2018-2029)
8.3 China Epigenetics Market Size by Application
8.3.1 China Epigenetics Market Size by Application (2018-2024)
8.3.2 China Epigenetics Market Size by Application (2024-2029)
8.3.3 China Epigenetics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Epigenetics Market Size (2018-2029)
9.2 Asia Epigenetics Market Size by Type
9.2.1 Asia Epigenetics Market Size by Type (2018-2024)
9.2.2 Asia Epigenetics Market Size by Type (2024-2029)
9.2.3 Asia Epigenetics Market Share by Type (2018-2029)
9.3 Asia Epigenetics Market Size by Application
9.3.1 Asia Epigenetics Market Size by Application (2018-2024)
9.3.2 Asia Epigenetics Market Size by Application (2024-2029)
9.3.3 Asia Epigenetics Market Share by Application (2018-2029)
9.4 Asia Epigenetics Market Size by Region
9.4.1 Asia Epigenetics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Epigenetics Market Size by Region (2018-2024)
9.4.3 Asia Epigenetics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Epigenetics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Epigenetics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Epigenetics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Epigenetics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Epigenetics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Epigenetics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Epigenetics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Epigenetics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Epigenetics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Epigenetics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Epigenetics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Epigenetics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Epigenetics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Epigenetics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Epigenetics Business (2018-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Epigenetics Introduction
11.2.4 Merck & Co. Revenue in Epigenetics Business (2018-2024)
11.2.5 Merck & Co. Recent Developments
11.3 Zymo Research
11.3.1 Zymo Research Company Details
11.3.2 Zymo Research Business Overview
11.3.3 Zymo Research Epigenetics Introduction
11.3.4 Zymo Research Revenue in Epigenetics Business (2018-2024)
11.3.5 Zymo Research Recent Developments
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Epigenetics Introduction
11.4.4 Abcam Revenue in Epigenetics Business (2018-2024)
11.4.5 Abcam Recent Developments
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Epigenetics Introduction
11.5.4 Qiagen Revenue in Epigenetics Business (2018-2024)
11.5.5 Qiagen Recent Developments
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Epigenetics Introduction
11.6.4 Illumina Revenue in Epigenetics Business (2018-2024)
11.6.5 Illumina Recent Developments
11.7 Active Motif
11.7.1 Active Motif Company Details
11.7.2 Active Motif Business Overview
11.7.3 Active Motif Epigenetics Introduction
11.7.4 Active Motif Revenue in Epigenetics Business (2018-2024)
11.7.5 Active Motif Recent Developments
11.8 Bio-Rad
11.8.1 Bio-Rad Company Details
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad Epigenetics Introduction
11.8.4 Bio-Rad Revenue in Epigenetics Business (2018-2024)
11.8.5 Bio-Rad Recent Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Epigenetics Introduction
11.9.4 New England Biolabs Revenue in Epigenetics Business (2018-2024)
11.9.5 New England Biolabs Recent Developments
11.10 Agilent
11.10.1 Agilent Company Details
11.10.2 Agilent Business Overview
11.10.3 Agilent Epigenetics Introduction
11.10.4 Agilent Revenue in Epigenetics Business (2018-2024)
11.10.5 Agilent Recent Developments
11.11 Perkinelmer
11.11.1 Perkinelmer Company Details
11.11.2 Perkinelmer Business Overview
11.11.3 Perkinelmer Epigenetics Introduction
11.11.4 Perkinelmer Revenue in Epigenetics Business (2018-2024)
11.11.5 Perkinelmer Recent Developments
11.12 Diagenode
11.12.1 Diagenode Company Details
11.12.2 Diagenode Business Overview
11.12.3 Diagenode Epigenetics Introduction
11.12.4 Diagenode Revenue in Epigenetics Business (2018-2024)
11.12.5 Diagenode Recent Developments
11.13 Epizyme Inc.
11.13.1 Epizyme Inc. Company Details
11.13.2 Epizyme Inc. Business Overview
11.13.3 Epizyme Inc. Epigenetics Introduction
11.13.4 Epizyme Inc. Revenue in Epigenetics Business (2018-2024)
11.13.5 Epizyme Inc. Recent Developments
11.14 CellCentric Ltd.
11.14.1 CellCentric Ltd. Company Details
11.14.2 CellCentric Ltd. Business Overview
11.14.3 CellCentric Ltd. Epigenetics Introduction
11.14.4 CellCentric Ltd. Revenue in Epigenetics Business (2018-2024)
11.14.5 CellCentric Ltd. Recent Developments
11.15 ValiRx plc
11.15.1 ValiRx plc Company Details
11.15.2 ValiRx plc Business Overview
11.15.3 ValiRx plc Epigenetics Introduction
11.15.4 ValiRx plc Revenue in Epigenetics Business (2018-2024)
11.15.5 ValiRx plc Recent Developments
11.16 EpiGentek
11.16.1 EpiGentek Company Details
11.16.2 EpiGentek Business Overview
11.16.3 EpiGentek Epigenetics Introduction
11.16.4 EpiGentek Revenue in Epigenetics Business (2018-2024)
11.16.5 EpiGentek Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Epigenetics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Enzymes
Table 3. Key Players of Kits & Assays
Table 4. Key Players of Instruments and Consumables
Table 5. Key Players of Reagents
Table 6. Global Epigenetics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Epigenetics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Epigenetics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Epigenetics Market Share by Region (2018-2024)
Table 10. Global Epigenetics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Epigenetics Market Share by Region (2024-2029)
Table 12. Epigenetics Market Trends
Table 13. Epigenetics Market Drivers
Table 14. Epigenetics Market Challenges
Table 15. Epigenetics Market Restraints
Table 16. Global Epigenetics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Epigenetics Revenue Share by Players (2018-2024)
Table 18. Global Top Epigenetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics as of 2022)
Table 19. Global Epigenetics Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Epigenetics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Epigenetics, Headquarters and Area Served
Table 22. Global Key Players of Epigenetics, Product and Application
Table 23. Global Key Players of Epigenetics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Epigenetics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Epigenetics Revenue Market Share by Type (2018-2024)
Table 27. Global Epigenetics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Epigenetics Revenue Market Share by Type (2024-2029)
Table 29. Global Epigenetics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Epigenetics Revenue Share by Application (2018-2024)
Table 31. Global Epigenetics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Epigenetics Revenue Share by Application (2024-2029)
Table 33. North America Epigenetics Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Epigenetics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Epigenetics Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Epigenetics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Epigenetics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Epigenetics Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Epigenetics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Epigenetics Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Epigenetics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Epigenetics Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Epigenetics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Epigenetics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Epigenetics Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Epigenetics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Epigenetics Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Epigenetics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Epigenetics Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Epigenetics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Epigenetics Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Epigenetics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Epigenetics Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Epigenetics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Epigenetics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Epigenetics Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Epigenetics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Epigenetics Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Epigenetics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Epigenetics Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Epigenetics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Epigenetics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Epigenetics Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Epigenetics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Thermo Fisher Scientific Company Details
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Epigenetics Product
Table 68. Thermo Fisher Scientific Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Developments
Table 70. Merck & Co. Company Details
Table 71. Merck & Co. Business Overview
Table 72. Merck & Co. Epigenetics Product
Table 73. Merck & Co. Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 74. Merck & Co. Recent Developments
Table 75. Zymo Research Company Details
Table 76. Zymo Research Business Overview
Table 77. Zymo Research Epigenetics Product
Table 78. Zymo Research Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 79. Zymo Research Recent Developments
Table 80. Abcam Company Details
Table 81. Abcam Business Overview
Table 82. Abcam Epigenetics Product
Table 83. Abcam Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 84. Abcam Recent Developments
Table 85. Qiagen Company Details
Table 86. Qiagen Business Overview
Table 87. Qiagen Epigenetics Product
Table 88. Qiagen Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 89. Qiagen Recent Developments
Table 90. Illumina Company Details
Table 91. Illumina Business Overview
Table 92. Illumina Epigenetics Product
Table 93. Illumina Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 94. Illumina Recent Developments
Table 95. Active Motif Company Details
Table 96. Active Motif Business Overview
Table 97. Active Motif Epigenetics Product
Table 98. Active Motif Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 99. Active Motif Recent Developments
Table 100. Bio-Rad Company Details
Table 101. Bio-Rad Business Overview
Table 102. Bio-Rad Epigenetics Product
Table 103. Bio-Rad Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 104. Bio-Rad Recent Developments
Table 105. New England Biolabs Company Details
Table 106. New England Biolabs Business Overview
Table 107. New England Biolabs Epigenetics Product
Table 108. New England Biolabs Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 109. New England Biolabs Recent Developments
Table 110. Agilent Company Details
Table 111. Agilent Business Overview
Table 112. Agilent Epigenetics Product
Table 113. Agilent Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 114. Agilent Recent Developments
Table 115. Perkinelmer Company Details
Table 116. Perkinelmer Business Overview
Table 117. Perkinelmer Epigenetics Product
Table 118. Perkinelmer Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 119. Perkinelmer Recent Developments
Table 120. Diagenode Company Details
Table 121. Diagenode Business Overview
Table 122. Diagenode Epigenetics Product
Table 123. Diagenode Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 124. Diagenode Recent Developments
Table 125. Epizyme Inc. Company Details
Table 126. Epizyme Inc. Business Overview
Table 127. Epizyme Inc. Epigenetics Product
Table 128. Epizyme Inc. Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 129. Epizyme Inc. Recent Developments
Table 130. CellCentric Ltd. Company Details
Table 131. CellCentric Ltd. Business Overview
Table 132. CellCentric Ltd. Epigenetics Product
Table 133. CellCentric Ltd. Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 134. CellCentric Ltd. Recent Developments
Table 135. ValiRx plc Company Details
Table 136. ValiRx plc Business Overview
Table 137. ValiRx plc Epigenetics Product
Table 138. ValiRx plc Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 139. ValiRx plc Recent Developments
Table 140. EpiGentek Company Details
Table 141. EpiGentek Business Overview
Table 142. EpiGentek Epigenetics Product
Table 143. EpiGentek Revenue in Epigenetics Business (2018-2024) & (US$ Million)
Table 144. EpiGentek Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Epigenetics Market Share by Type: 2022 VS 2029
Figure 3. Enzymes Features
Figure 4. Kits & Assays Features
Figure 5. Instruments and Consumables Features
Figure 6. Reagents Features
Figure 7. Global Epigenetics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Epigenetics Market Share by Application: 2022 VS 2029
Figure 9. Academic & Research Institutes Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Biotechnology Companies Case Studies
Figure 12. Contract Research Organizations (CROs) Case Studies
Figure 13. Others Case Studies
Figure 14. Epigenetics Report Years Considered
Figure 15. Global Epigenetics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Epigenetics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Epigenetics Market Share by Region: 2022 VS 2029
Figure 18. Global Epigenetics Market Share by Players in 2022
Figure 19. Global Top Epigenetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Epigenetics Revenue in 2022
Figure 21. North America Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Epigenetics Market Share by Type (2018-2029)
Figure 23. North America Epigenetics Market Share by Application (2018-2029)
Figure 24. North America Epigenetics Market Share by Country (2018-2029)
Figure 25. United States Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Epigenetics Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Epigenetics Market Share by Type (2018-2029)
Figure 29. Europe Epigenetics Market Share by Application (2018-2029)
Figure 30. Europe Epigenetics Market Share by Country (2018-2029)
Figure 31. Germany Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Epigenetics Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Epigenetics Market Share by Type (2018-2029)
Figure 39. China Epigenetics Market Share by Application (2018-2029)
Figure 40. Asia Epigenetics Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Epigenetics Market Share by Type (2018-2029)
Figure 42. Asia Epigenetics Market Share by Application (2018-2029)
Figure 43. Asia Epigenetics Market Share by Region (2018-2029)
Figure 44. Japan Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Epigenetics Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Epigenetics Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Epigenetics Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Epigenetics Market Share by Country (2018-2029)
Figure 54. Brazil Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Epigenetics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 61. Merck & Co. Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 62. Zymo Research Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 63. Abcam Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 64. Qiagen Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 65. Illumina Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 66. Active Motif Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 67. Bio-Rad Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 68. New England Biolabs Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 69. Agilent Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 70. Perkinelmer Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 71. Diagenode Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 72. Epizyme Inc. Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 73. CellCentric Ltd. Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 74. ValiRx plc Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 75. EpiGentek Revenue Growth Rate in Epigenetics Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed